Mycophenolate mofetil Active Not Recruiting Phase 2 Trials for Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Recurrent Plasma Cell Myeloma / Refractory Mantle Cell Lymphoma / Recurrent Mantle Cell Lymphoma / Recurrent Small Lymphocytic Lymphoma / Refractory Small Lymphocytic Lymphoma / Myelodysplastic Syndrome / T-Cell Non-Hodgkin Lymphoma / Aggressive Non-Hodgkin Lymphoma / chronic, recurrent Lymphocytic Leukemia / Leukemia Acute Myeloid Leukemia (AML) / Refractory Follicular Lymphoma / Refractory Hodgkin Lymphoma / Recurrent Follicular Lymphoma / Refractory Lymphoplasmacytic Lymphoma / Mixed Phenotype Acute Leukemia (MPAL) / Acute Lymphoblastic Leukaemias (ALL) / Recurrent Lymphoplasmacytic Lymphoma / Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Recurrent Marginal Zone Lymphoma / Chronic Lymphocytic Leukemia (CLL) - Refractory / Myeloproliferative Neoplasms / Acute Biphenotypic Leukemia (ABL) / Recurrent T-Cell Non-Hodgkin Lymphoma / Indolent Non-Hodgkin's Lymphomas / Malignant Lymphomas / Malignant Lymphoma, Large Cell Type Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00574496Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma
NCT01252667Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant